Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

Global Cancer Vaccines Market Size study, by Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), by Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), by Indication (Cervical Cancer, Prostate Cancer, Others), by End-User (Pediatrics, Adults) and Regional Forecasts 2020-2027

  • BIZ4026468
  • 200 Pages
  • August 2020
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Global Cancer Vaccines Market is valued at approximately USD 4.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2020-2027. Cancer vaccines are a form of immunotherapy which is considered as a biological response modifier. Usually, cancer treatment vaccines are distinct from the vaccines that work against bacteria and viruses. Cancer vaccines can stimulate the immune system of the patient’s body to fight against cancer cells. Rather than preventing disease, these vaccines are primarily focused to boost the immune systems to medicate a disease that already occurred in the patient’s body. The cancer vaccines are generally available in two types i.e. preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines are typically used to prevent cancer disease among healthy people, whereas therapeutic cancer vaccines are used to strengthen the immune response among patients to fight against the disease. An increase in the number of cancer patients, growing awareness among patients towards cancer therapy, and rising investment and government funding in the development of cancer vaccine are the few factors responsible for the CAGR of the market during the forecast period. According to the International Agency for Research on Cancer (IARC), around 18.1 million new cancer cases and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for Cancer Vaccines, globally. However, the high development cost of vaccine and stringent government norms & policies on product approval are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Cancer Vaccines market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable government support for the approval of cancer vaccines, along with the wide presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.

Major market player included in this report are:

Advaxis Inc.

Amgen Inc.

Dynavax Technologies Corporation

Generex Biotechnology Corporation

GlaxoSmithKline plc (GSK)

Immunocellular Therapeutics, Ltd.

Merck & Co., Inc.

Sanpower Group Co. Ltd.

UbiVac, Inc.

Vaccinogen, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

By Technology:

Dendritic Cells (DC) Cancer Vaccines

Recombinant Cancer Vaccines

Antigen/Adjuvant Cancer Vaccines

Viral Vector & DNA Cancer Vaccines

By Indication:

Cervical Cancer

Prostate Cancer

Others

By End-User:

Pediatrics

Adults

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Cancer Vaccines Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Cancer Vaccines Market, by Region, 2018-2027 (USD Billion)

1.2.2. Cancer Vaccines Market, by Type, 2018-2027 (USD Billion)

1.2.3. Cancer Vaccines Market, by Technology, 2018-2027 (USD Billion)

1.2.4. Cancer Vaccines Market, by Indication, 2018-2027 (USD Billion)

1.2.5. Cancer Vaccines Market, by End-User, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Cancer Vaccines Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Cancer Vaccines Market Dynamics

3.1. Cancer Vaccines Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Cancer Vaccines Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Vaccines Market, by Type

5.1. Market Snapshot

5.2. Global Cancer Vaccines Market by Type, Performance - Potential Analysis

5.3. Global Cancer Vaccines Market Estimates & Forecasts by Type 2017-2027 (USD Billion)

5.4. Cancer Vaccines Market, Sub Segment Analysis

5.4.1. Preventive Cancer Vaccines

5.4.2. Therapeutic Cancer Vaccines

Chapter 6. Global Cancer Vaccines Market, by Technology

6.1. Market Snapshot

6.2. Global Cancer Vaccines Market by Technology, Performance - Potential Analysis

6.3. Global Cancer Vaccines Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)

6.4. Cancer Vaccines Market, Sub Segment Analysis

6.4.1. Dendritic Cells (DC) Cancer Vaccines

6.4.2. Recombinant Cancer Vaccines

6.4.3. Antigen/Adjuvant Cancer Vaccines

6.4.4. Viral Vector & DNA Cancer Vaccines

Chapter 7. Global Cancer Vaccines Market, by Indication

7.1. Market Snapshot

7.2. Global Cancer Vaccines Market by Indication, Performance - Potential Analysis

7.3. Global Cancer Vaccines Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)

7.4. Cancer Vaccines Market, Sub Segment Analysis

7.4.1. Cervical Cancer

7.4.2. Prostate Cancer

7.4.3. Others

Chapter 8. Global Cancer Vaccines Market, by End-User

8.1. Market Snapshot

8.2. Global Cancer Vaccines Market by End-User - Potential Analysis

8.3. Global Cancer Vaccines Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)

8.4. Cancer Vaccines Market, Sub Segment Analysis

8.4.1. Paediatrics

8.4.2. Adults

Chapter 9. Global Cancer Vaccines Market, Regional Analysis

9.1. Cancer Vaccines Market, Regional Market Snapshot

9.2. North America Cancer Vaccines Market

9.2.1. U.S. Cancer Vaccines Market

9.2.1.1. Type breakdown estimates & forecasts, 2017-2027

9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027

9.2.1.3. Indication breakdown estimates & forecasts, 2017-2027

9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027

9.2.2. Canada Cancer Vaccines Market

9.3. Europe Cancer Vaccines Market Snapshot

9.3.1. U.K. Cancer Vaccines Market

9.3.2. Germany Cancer Vaccines Market

9.3.3. France Cancer Vaccines Market

9.3.4. Spain Cancer Vaccines Market

9.3.5. Italy Cancer Vaccines Market

9.3.6. Rest of Europe Cancer Vaccines Market

9.4. Asia-Pacific Cancer Vaccines Market Snapshot

9.4.1. China Cancer Vaccines Market

9.4.2. India Cancer Vaccines Market

9.4.3. Japan Cancer Vaccines Market

9.4.4. Australia Cancer Vaccines Market

9.4.5. South Korea Cancer Vaccines Market

9.4.6. Rest of Asia Pacific Cancer Vaccines Market

9.5. Latin America Cancer Vaccines Market Snapshot

9.5.1. Brazil Cancer Vaccines Market

9.5.2. Mexico Cancer Vaccines Market

9.6. Rest of The World Cancer Vaccines Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Advaxis Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Amgen Inc.

10.2.3. Dynavax Technologies Corporation

10.2.4. Generex Biotechnology Corporation

10.2.5. GlaxoSmithKline plc (GSK)

10.2.6. Immunocellular Therapeutics, Ltd.

10.2.7. Merck & Co., Inc.

10.2.8. Sanpower Group Co. Ltd.

10.2.9. UbiVac, Inc.

10.2.10. Vaccinogen, Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

TABLE 1. Global Cancer Vaccines market, report scope

TABLE 2. Global Cancer Vaccines market estimates & forecasts by region 2017-2027 (USD Billion)

TABLE 3. Global Cancer Vaccines market estimates & forecasts by Type 2017-2027 (USD Billion)

TABLE 4. Global Cancer Vaccines market estimates & forecasts by Technology 2017-2027 (USD Billion)

TABLE 5. Global Cancer Vaccines market estimates & forecasts by Indication 2017-2027 (USD Billion)

TABLE 6. Global Cancer Vaccines market estimates & forecasts by End-User 2017-2027 (USD Billion)

TABLE 7. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 20. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 21. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 23. U.S. Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 24. U.S. Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 25. U.S. Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 26. Canada Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 27. Canada Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 28. Canada Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 29. UK Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 30. UK Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 31. UK Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 32. Germany Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 33. Germany Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 34. Germany Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 35. France Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 36. France Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 37. France Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 38. Spain Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 39. Spain Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 40. Spain Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 41. Italy Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 42. Italy Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 43. Italy Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 44. ROE Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 45. ROE Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 46. ROE Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 47. China Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 48. China Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 49. China Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 50. India Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 51. India Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 52. India Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 53. Japan Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 54. Japan Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 55. Japan Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 56. Australia Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 57. Australia Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 58. Australia Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 59. South Korea Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 60. South Korea Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 61. South Korea Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 62. ROPAC Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 63. ROPAC Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 64. ROPAC Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 65. Brazil Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 66. Brazil Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 67. Brazil Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 68. Mexico Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 69. Mexico Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 70. Mexico Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 71. ROLA Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 72. ROLA Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 73. ROLA Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 74. ROW Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 75. ROW Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 76. ROW Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 77. List of secondary End-Users, used in the study of global Cancer Vaccines market

TABLE 78. List of primary End-Users, used in the study of global Cancer Vaccines market

TABLE 79. Years considered for the study

TABLE 80. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research